Common Litalir Side Effects


The most commonly reported Litalir side effects (click to view or check a box to report):

Polyneuropathy (4)
Off Label Use (3)
Malignant Neoplasm Progression (3)
Bronchopulmonary Aspergillosis (3)
Haematoma (2)
Headache (2)
Fatigue (2)
Premature Baby (2)
Urticaria (2)
Rash (2)
Lethargy (1)
Lactic Acidosis (1)
Interstitial Lung Disease (1)
Leukopenia (1)
Keratosis Follicular (1)
Menopausal Symptoms (1)
Nervous System Disorder (1)
Muscle Spasms (1)
Muscle Contractions Involuntary (1)
Lymphocyte Count Decreased (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Litalir Side Effects Reported to FDA



Litalir Side Effect Report#9838525
Menopausal Symptoms, Night Sweats, Insomnia, Stress, Fatigue, Off Label Use
This is a report of a 51-year-old female patient (weight: NA) from DE, suffering from the following health symptoms/conditions: polycythaemia, who was treated with Litalir (dosage: Capsule, start time: NS), combined with:
  • Remifemin
  • Opipramol
and developed a serious reaction and side effect(s): Menopausal Symptoms, Night Sweats, Insomnia, Stress, Fatigue, Off Label Use after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Litalir treatment in female patients, resulting in Menopausal Symptoms side effect.
Litalir Side Effect Report#9795580
Keratosis Follicular, Off Label Use
This report suggests a potential Litalir Keratosis Follicular side effect(s) that can have serious consequences. A 55-year-old female patient (weight: NA) from DE was diagnosed with the following symptoms/conditions: essential thrombocythaemia and used Litalir (dosage: 25sep2009?2000mg- Total Dose Daily) starting
May 25, 2009. After starting Litalir the patient began experiencing various side effects, including: Keratosis Follicular, Off Label UseAdditional drugs used concurrently:
  • Linola-fett
  • Hydroxyzine
  • Paspertin
  • Metamizole
  • Trevilor
Although Litalir demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Keratosis Follicular, may still occur.
Litalir Side Effect Report#9336937
Dysphagia
This Death problem was reported by a pharmacist from DE. A 93-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Litalir Caps (dosage: Threapy Continuing From Last Year.). The following drugs were being taken at the same time: NA. When using Litalir Caps, the patient experienced the following unwanted symptoms/side effects: DysphagiaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Death, may become evident only after a product is in use by the general population.
Litalir Side Effect Report#9331634
Eye Irritation, Dizziness, Cataract
This Eye Irritation side effect was reported by a physician from DE. A 81-year-old female patient (weight:NA) experienced the following symptoms/conditions: essential thrombocythaemia.The patient was prescribed Litalir Caps (drug dosage: Capsules For 11 Years ?dose Regimen: 1cap On 1+2 Day?2capsule On 3day.1-1-2), which was initiated on 2002. Concurrently used drugs:
  • Ass
.After starting to take Litalir Caps the consumer reported adverse symptoms, such as: Eye Irritation, Dizziness, CataractThese side effects may potentially be related to Litalir Caps.
Litalir Side Effect Report#9311356
Type I Hypersensitivity, Rash, Pruritus Genital, Off Label Use
This is a report of a 50-year-old female patient (weight: NA) from CH, suffering from the following health symptoms/conditions: acute myeloid leukaemia, who was treated with Litalir Caps (dosage: NA, start time:
Mar 21, 2013), combined with:
  • Tretinoin (40 Mg Caps;1x12h)
  • Trisenox (1x/d Iv Over 3 Hours 21mar2013)
  • Cefepime For Inj
  • Dexamethasone
  • Heparin
  • Magnesium Sulfate
  • Paspertin
  • Noxafil
and developed a serious reaction and side effect(s): Type I Hypersensitivity, Rash, Pruritus Genital, Off Label Use after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Litalir Caps treatment in female patients, resulting in Type I Hypersensitivity side effect.
Litalir Side Effect Report#9203751
Interstitial Lung Disease
This report suggests a potential Litalir Caps Interstitial Lung Disease side effect(s) that can have serious consequences. A 76-year-old male patient (weight: NA) from DE was diagnosed with the following symptoms/conditions: chronic myeloid leukaemia and used Litalir Caps (dosage: NA) starting 2009. After starting Litalir Caps the patient began experiencing various side effects, including: Interstitial Lung DiseaseAdditional drugs used concurrently: NA.The patient was hospitalized. Although Litalir Caps demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Interstitial Lung Disease, may still occur.
Litalir Side Effect Report#9192844
Infertility
This Infertility problem was reported by a consumer or non-health professional from DE. A 45-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: polycythaemia vera. On NS this consumer started treatment with Litalir (dosage: 3 Hard Caps). The following drugs were being taken at the same time: NA. When using Litalir, the patient experienced the following unwanted symptoms/side effects: InfertilityAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Infertility, may become evident only after a product is in use by the general population.
Litalir Side Effect Report#9027345
Hepatitis B, Thrombosis
This Hepatitis B side effect was reported by a consumer or non-health professional from DE. A 90-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Litalir (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Litalir the consumer reported adverse symptoms, such as: Hepatitis B, ThrombosisThese side effects may potentially be related to Litalir.
Litalir Side Effect Report#8971698
Premature Baby
This is a report of a male patient (weight: NA) from DE, suffering from the following health symptoms/conditions: NA, who was treated with Litalir (dosage: 2 X 500mg/day, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Premature Baby after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Litalir treatment in male patients, resulting in Premature Baby side effect.
Litalir Side Effect Report#8971697
Premature Baby
This report suggests a potential Litalir Premature Baby side effect(s) that can have serious consequences. A female patient (weight: NA) from DE was diagnosed with the following symptoms/conditions: NA and used Litalir (dosage: 2 X 500mg/day) starting NS. After starting Litalir the patient began experiencing various side effects, including: Premature BabyAdditional drugs used concurrently: NA. Although Litalir demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Premature Baby, may still occur.
Litalir Side Effect Report#7118168-5
Confusional State, Pyrexia
This Confusional State problem was reported by a physician from Germany. A 69-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: polycythaemia vera. On NS this consumer started treatment with Litalir Caps (dosage: 1 Df:one Capsule At Total Of Two Re-expositions.). The following drugs were being taken at the same time: NA. When using Litalir Caps, the patient experienced the following unwanted symptoms/side effects: Confusional State, PyrexiaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Confusional State, may become evident only after a product is in use by the general population.
Litalir Side Effect Report#6576626-6
Dehydration, Hyperkalaemia, Renal Failure Chronic
This Dehydration side effect was reported by a physician from Croatia (local Name: Hrvatska). A 81-year-old female patient (weight:NA) experienced the following symptoms/conditions: polycythaemia vera.The patient was prescribed Litalir Caps 500 Mg (drug dosage: Stopped On 19jan2010, Restarted On Unk Date Duration 1.5 Years), which was initiated on
Jan 01, 2008. Concurrently used drugs:
  • Furosemide
  • Isoptin
  • Spironolactone
.After starting to take Litalir Caps 500 Mg the consumer reported adverse symptoms, such as: Dehydration, Hyperkalaemia, Renal Failure ChronicThese side effects may potentially be related to Litalir Caps 500 Mg.
Litalir Side Effect Report#6432948-0
Corneal Opacity
This is a report of a 64-year-old female patient (weight: NA) from Germany, suffering from the following health symptoms/conditions: thrombocytosis,activated protein c resistance,hypertension, who was treated with Litalir Caps (dosage: Caps, start time:
Feb 01, 2008), combined with:
  • Marcumar (1df- Half A Tab)
  • Atacand Hct (1df- 1 Tab)
  • Carmen (Tablets)
  • Paroxetine (Tablets)
and developed a serious reaction and side effect(s): Corneal Opacity after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Litalir Caps treatment in female patients, resulting in Corneal Opacity side effect.
Litalir Side Effect Report#6101062-6
Cholestatic Liver Injury, Hyperammonaemia, Lactic Acidosis, Renal Failure Acute
This report suggests a potential Litalir Caps 500 Mg Cholestatic Liver Injury side effect(s) that can have serious consequences. A 61-year-old female patient (weight: NA) from Switzerland was diagnosed with the following symptoms/conditions: NA and used Litalir Caps 500 Mg (dosage: NA) starting
Jan 01, 2006. After starting Litalir Caps 500 Mg the patient began experiencing various side effects, including: Cholestatic Liver Injury, Hyperammonaemia, Lactic Acidosis, Renal Failure AcuteAdditional drugs used concurrently:
  • Cefuroxime
  • Cefuroxime
  • Metformin Hcl
  • Amaryl (Form: Tab)
  • Aspirin (Form: Enteric Coated Tab (ass Cardio Spirig))
  • Cozaar
  • Pantozol (Form: Tab)
  • Sortis (Form: Film Coated Tablets)
The patient was hospitalized. Although Litalir Caps 500 Mg demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Cholestatic Liver Injury, may still occur.
Litalir Side Effect Report#6088662-7
Atrioventricular Block, Cholestasis, Hepatitis Cholestatic, Influenza, Respiratory Failure
This Atrioventricular Block problem was reported by a physician from Switzerland. A 63-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: myeloproliferative disorder. On
Jan 01, 1998 this consumer started treatment with Litalir Caps 500 Mg (dosage: NA). The following drugs were being taken at the same time:
  • Cordarone
  • Carvedilol
  • Rasilez (Coated Tabs Film)
  • Aldozone
  • Arimidex (Coated Tabs Film)
  • Sintrom (Long Term Use)
  • Omeprazole (Duration= Long Term Use)
When using Litalir Caps 500 Mg, the patient experienced the following unwanted symptoms/side effects: Atrioventricular Block, Cholestasis, Hepatitis Cholestatic, Influenza, Respiratory FailureThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Atrioventricular Block, may become evident only after a product is in use by the general population.
Litalir Side Effect Report#5833210-7
Nervous System Disorder
This Nervous System Disorder side effect was reported by a physician from Germany. A 42-year-old female patient (weight:NA) experienced the following symptoms/conditions: polycythaemia vera.The patient was prescribed Litalir Caps 500 Mg (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Litalir Caps 500 Mg the consumer reported adverse symptoms, such as: Nervous System DisorderThese side effects may potentially be related to Litalir Caps 500 Mg.
Litalir Side Effect Report#5814455-9
Parkinson's Disease, Rash, Vitiligo
This is a report of a 70-year-old male patient (weight: NA) from Germany, suffering from the following health symptoms/conditions: polycythaemia vera, who was treated with Litalir Caps 500 Mg (dosage: Interrupted For 4 Weeks In 2002 And Was Restarted.discontinued Again For 4 Weeks In 2008, start time:
Jan 01, 2002), combined with: NA. and developed a serious reaction and side effect(s): Parkinson's Disease, Rash, Vitiligo after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Litalir Caps 500 Mg treatment in male patients, resulting in Parkinson's Disease side effect.
Litalir Side Effect Report#5677428-5
Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Basophil Percentage Increased, Blood Bilirubin Increased, Granulocyte Count Increased, Haematocrit Increased, Hepatic Enzyme Increased, Leukopenia, Lymphocyte Count Decreased
This report suggests a potential Litalir Caps Alanine Aminotransferase Increased side effect(s) that can have serious consequences. A 80-year-old female patient (weight: NA) from Germany was diagnosed with the following symptoms/conditions: polycythaemia vera and used Litalir Caps (dosage: Dosage Form = Caps) starting NS. After starting Litalir Caps the patient began experiencing various side effects, including: Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Basophil Percentage Increased, Blood Bilirubin Increased, Granulocyte Count Increased, Haematocrit Increased, Hepatic Enzyme Increased, Leukopenia, Lymphocyte Count DecreasedAdditional drugs used concurrently: NA. Although Litalir Caps demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Alanine Aminotransferase Increased, may still occur.
Litalir Side Effect Report#5222513-5
Cerebrovascular Accident, Hallucination
This Cerebrovascular Accident problem was reported by a physician from Germany. A 82-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: thrombocythaemia. On NS this consumer started treatment with Litalir (dosage: NA). The following drugs were being taken at the same time: NA. When using Litalir, the patient experienced the following unwanted symptoms/side effects: Cerebrovascular Accident, HallucinationThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cerebrovascular Accident, may become evident only after a product is in use by the general population.
Litalir Side Effect Report#5201240-4
Bronchopulmonary Aspergillosis, Malignant Neoplasm Progression
This Bronchopulmonary Aspergillosis side effect was reported by a consumer or non-health professional from Germany. A 59-year-old male patient (weight:NA) experienced the following symptoms/conditions: glioblastoma multiforme.The patient was prescribed Litalir (drug dosage: NA), which was initiated on
Apr 12, 2006. Concurrently used drugs:
  • Gleevec
.After starting to take Litalir the consumer reported adverse symptoms, such as: Bronchopulmonary Aspergillosis, Malignant Neoplasm ProgressionThese side effects may potentially be related to Litalir. The patient was hospitalized.
Litalir Side Effect Report#5154141-4
Bronchopulmonary Aspergillosis, Malignant Neoplasm Progression
This is a report of a 59-year-old male patient (weight: NA) from Germany, suffering from the following health symptoms/conditions: glioblastoma multiforme, who was treated with Litalir (dosage: NA, start time:
Apr 12, 2006), combined with:
  • Gleevec
and developed a serious reaction and side effect(s): Bronchopulmonary Aspergillosis, Malignant Neoplasm Progression after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Litalir treatment in male patients, resulting in Bronchopulmonary Aspergillosis side effect. The patient was hospitalized.
Litalir Side Effect Report#5148959-1
Haematoma, Urticaria
This report suggests a potential Litalir Caps Haematoma side effect(s) that can have serious consequences. A 64-year-old female patient (weight: NA) from Germany was diagnosed with the following symptoms/conditions: chronic myeloid leukaemia and used Litalir Caps (dosage: NA) starting
Jan 26, 2006. After starting Litalir Caps the patient began experiencing various side effects, including: Haematoma, UrticariaAdditional drugs used concurrently:
  • Tramadol Hcl
  • Torsemide
  • Acimethin
Although Litalir Caps demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Haematoma, may still occur.
Litalir Side Effect Report#5120006-7
Haematoma, Urticaria
This Haematoma problem was reported by a pharmacist from Germany. A 64-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: chronic myeloid leukaemia. On
Jan 26, 2006 this consumer started treatment with Litalir Caps (dosage: NA). The following drugs were being taken at the same time:
  • Tramadol Hcl
  • Torsemide
  • Acimethin
When using Litalir Caps, the patient experienced the following unwanted symptoms/side effects: Haematoma, UrticariaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Haematoma, may become evident only after a product is in use by the general population.
Litalir Side Effect Report#5056001-6
Bronchopulmonary Aspergillosis
This Bronchopulmonary Aspergillosis side effect was reported by a consumer or non-health professional from Germany. A 59-year-old male patient (weight:NA) experienced the following symptoms/conditions: glioblastoma multiforme.The patient was prescribed Litalir (drug dosage: NA), which was initiated on
Apr 12, 2006. Concurrently used drugs:
  • Gleevec
.After starting to take Litalir the consumer reported adverse symptoms, such as: Bronchopulmonary AspergillosisThese side effects may potentially be related to Litalir. The patient was hospitalized.
Litalir Side Effect Report#5048859-1
Headache, Heart Rate Increased, Hyperhidrosis, Muscle Contractions Involuntary, Muscle Spasms
This is a report of a 36-year-old male patient (weight: NA) from Germany, suffering from the following health symptoms/conditions: glioblastoma, who was treated with Litalir (dosage: NA, start time:
Mar 17, 2006), combined with:
  • Gleevec
  • Dexamethasone Tab
  • Pantoprazole
  • Lamotrigine
  • Keppra
  • Kalinor
and developed a serious reaction and side effect(s): Headache, Heart Rate Increased, Hyperhidrosis, Muscle Contractions Involuntary, Muscle Spasms after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Litalir treatment in male patients, resulting in Headache side effect.


1 of 2 


The appearance of Litalir on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Litalir Side Effects for Women?

Women Side Effects Reports
Off Label Use 3
Fatigue 2
Haematoma 2
Polyneuropathy 2
Urticaria 2
Alanine Aminotransferase Increased 1
Aspartate Aminotransferase Increased 1
Atrioventricular Block 1
Basophil Percentage Increased 1
Blood Bilirubin Increased 1

What are common Litalir Side Effects for Men?

Men Side Effects Reports
Bronchopulmonary Aspergillosis 3
Malignant Neoplasm Progression 3
Headache 2
Polyneuropathy 2
Brain Oedema 1
Confusional State 1
Glioblastoma 1
Heart Rate Increased 1
Hepatitis B 1
Hyperhidrosis 1

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Litalir reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Litalir Side Effects

    Did You Have a Litalir Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Litalir for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Litalir Safety Alerts, Active Ingredients, Usage Information

    More About Litalir

    Side Effects reported to FDA: 32

    Litalir safety alerts: No

    Reported deaths: 3

    Reported hospitalizations: 6

    Latest Litalir clinical trials

    Litalir Reviews

    No reviews, be a first to report a side effect via side effect reporting form

    privacy policy